Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaids PharmaceuticalsBOM:524572 +1.89%23 Days Payable is 156.88 as of Jun. 2026, which is 23% below its 10-year median of 203.23. GuruFocus rates BOM:524572 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 924 Drug Manufacturers companies, Pharmaids Pharmaceuticals ranks better than 89.18% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pharmaids Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaids Pharmaceuticals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharmaids Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where Pharmaids Pharmaceuticals's Days Payable falls into.
Pharmaids Pharmaceuticals Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pharmaids Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaids Pharmaceuticals (BOM:524572) has a Days Payable of 156.88 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharmaids Pharmaceuticals and its competitors. This is 23% below median its historical median of 203.23. Over the past decade, Pharmaids Pharmaceuticals' Days Payable has ranged from 11.46 to 861.28. According to the industry distribution chart, Pharmaids Pharmaceuticals ranks #100 out of 924 companies in the Drug Manufacturers industry, placing it in the top 10.8%.
Is Pharmaids Pharmaceuticals' Days Payable too high?
Pharmaids Pharmaceuticals' current Days Payable of 156.88 is 23% below median its 10-year median of 203.23. Over the past 10 years, this metric has ranged from a low of 11.46 to a high of 861.28. The Drug Manufacturers industry median Days Payable is 88.80. Pharmaids Pharmaceuticals' value of 156.88 is 76.7% above this industry median. Based on the distribution chart, Pharmaids Pharmaceuticals ranks #100 out of 924 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pharmaids Pharmaceuticals has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Pharmaids Pharmaceuticals' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pharmaids Pharmaceuticals ranks #100 out of 924 companies for Days Payable. This places Pharmaids Pharmaceuticals in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 88.80. Pharmaids Pharmaceuticals' value of 156.88 is 76.7% above this benchmark. Historically, Pharmaids Pharmaceuticals' own Days Payable has ranged from 11.46 to 861.28 over the past decade. While the company's 10-year median is 203.23 vs. the industry median of 88.80, Pharmaids Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.80, based on 924 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmaids Pharmaceuticals's current Days Payable of 156.88 is 76.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharmaids Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaids Pharmaceuticals's current Days Payable is 156.88, which is 23% below median its own 10-year median of 203.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaids Pharmaceuticals stock overvalued right now?
Pharmaids Pharmaceuticals (BOM:524572) has a current Days Payable of 156.88. The current Days Payable is 156.88, which is 23% below median its 10-year median of 203.23 and 76.7% above the Drug Manufacturers industry median of 88.80. Pharmaids Pharmaceuticals' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pharmaids Pharmaceuticals (BOM:524572), the current Days Payable is 156.88 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmaids Pharmaceuticals Ltd is an Indian pharmaceutical company that manufactures specialty chemicals, skin care products, hospital care products, and generic drugs. Its product range includes vitamins and related compounds, hand sanitizers, antiseptic solutions, ointments, and various bulk drugs. The company operates from Hyderabad, India, serving domestic and select international markets. Pharmaids generates revenue prominently from the sale of these pharmaceutical and healthcare products. Its operations focus on manufacturing and supplying formulations across healthcare and personal care segments.
23GF Score
Get the complete analysis for BOM:524572
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524572 has been successfully added to your 
